Clinical Trials Directory

Trials / Completed

CompletedNCT07126938

Alcohol Impairment Detection in Healthy Adult Users With the Gaize Device

An Observational Study to Facilitate the Development of an Alcohol Impairment Detection Device in Healthy Adult Alcohol Users

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Gaize · Industry
Sex
All
Age
21 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study evaluates the effectiveness of the Gaize virtual reality headset as a non-invasive tool for detecting alcohol-related impairment through ophthalmic and neurological indicators. A total of 80 participants, evenly divided into an experimental (alcohol-consuming) and control (non-alcohol consuming) group, underwent baseline and post-consumption ocular assessments using the device. These assessments included: Lack of Smooth Pursuit, Horizontal Gaze Nystagmus at Maximum Deviation, Horizontal Gaze Nystagmus with Onset Prior to 45-Degrees, Vertical Gaze Nystagmus, Lack of Convergence, and Pupillary Rebound Dilation. The Gaize headset measured gaze vector and pupil size at 90 hertz per eye.

Conditions

Interventions

TypeNameDescription
DRUGAlcoholic beverageParticipants in the experimental group consumed self-selected amounts of alcohol, monitored by study staff to ensure safety and compliance with protocol guidelines. Participants then filled out the remainder of the general health questionnaire, including how many drinks they consumed, and whether or not they feel too impaired to drive a vehicle or go to work.

Timeline

Start date
2024-03-21
Primary completion
2024-11-22
Completion
2024-11-22
First posted
2025-08-17
Last updated
2025-08-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07126938. Inclusion in this directory is not an endorsement.